A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer. (Record no. 8348712)

MARC details
000 -LEADER
fixed length control field 01492 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513073512.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199309s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0167-6997
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/BF00873911
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pfister, D G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19930915
245 00 - TITLE STATEMENT
Title A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Investigational new drugs
Date of publication, distribution, etc. Feb 1993
300 ## - PHYSICAL DESCRIPTION
Extent 53-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Squamous Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs, Investigational
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Guanidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Head and Neck Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bajorin, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Motzer, R J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scher, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Louison, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Harrison, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shah, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Strong, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bosl, G
773 0# - HOST ITEM ENTRY
Title Investigational new drugs
Related parts vol. 11
-- no. 1
-- p. 53-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/BF00873911">https://doi.org/10.1007/BF00873911</a>
Public note Available from publisher's website

No items available.